GENNIEFY
Market News
Latest financial news and analysis from global markets
INTC
If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026
CNBC commentator Jim Cramer sees value in the artificial intelligence (AI) realm beyond the technology sector.
INTC
Verizon Communications Stock Is Soaring in 2026. Here's Why It Can Still Go Higher
Verizon's stock has been struggling for years, and it may be overdue for a big rally.
NVDA
Verizon Communications Stock Is Soaring in 2026. Here's Why It Can Still Go Higher
Verizon's stock has been struggling for years, and it may be overdue for a big rally.
TSLA
Stock Market Today, March 23: Tesla Rises on Joint Venture Plans to Build a Semiconductor Plant for AI Chip Production
Today, March 23, 2026, investors rallied around Tesla's potential long-term AI roadmap.
ORCL
Stock Market Today, March 23: Palantir Rises After the Pentagon Designates Maven Program of Record
Palantir rose after the Pentagon designated its Maven AI platform a program of record, while a new U.K. regulatory trial highlights potential expansion beyond defense into commercial applications.
PLTR
Stock Market Today, March 23: Palantir Rises After the Pentagon Designates Maven Program of Record
Palantir rose after the Pentagon designated its Maven AI platform a program of record, while a new U.K. regulatory trial highlights potential expansion beyond defense into commercial applications.
MSFT
Stock Market Today, March 23: Palantir Rises After the Pentagon Designates Maven Program of Record
Palantir rose after the Pentagon designated its Maven AI platform a program of record, while a new U.K. regulatory trial highlights potential expansion beyond defense into commercial applications.
HON
Iran war is pushing need for energy efficiency: Honeywell CEO
CERAWeek 2026 — S&P Global's annual energy conference — has kicked off on Monday as business leaders and officials convene in Houston to address the industry's biggest innovations and issues. This all comes as the Iran war stretches into its fourth week and fluctuating oil prices (CL=F, BZ=F) fall back below $100 per barrel. Honeywell International (HON) chairman and CEO Vimal Kapur sits down with Yahoo Finance Anchor Julie Hyman to talk about the impacts that the defense contractor has already seen at overseas facilities as a result of escalating conflicts in the Middle East.
TDOC
3 Stocks Under $10 Walking a Fine Line
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.
XAU/USD
Hecla Mining Faces New Volatility As Leveraged ETF Targets The Stock
A new single stock leveraged ETF tied to Hecla Mining (NYSE:HL) is launching, offering amplified exposure to the company. The fund is designed to track daily moves in Hecla Mining shares with leverage, affecting both long and short positioning. This product represents a move from broader mining and metals ETFs toward more focused tools for trading individual miners. Hecla Mining, listed on the NYSE under ticker HL, is a precious metals producer with a focus on silver and gold. The launch of...
AMZN
How The Amazon.com (AMZN) Investment Story Is Shifting With AI, Cloud And Capex Commitments
Amazon.com’s latest update keeps the model fair value anchored at US$280.47, signaling that the core price target is unchanged in this round of analysis. That stability comes as analysts weigh large AI, cloud, advertising, logistics, and retail opportunities against heavy capex needs and competitive pressure, which has led to a mix of higher and lower price targets across the Street. As you read on, you will see how to track these shifting views and what to watch as the Amazon story continues...
ABBV
AbbVie’s ABBV-295 Obesity Data Opens New Non Incretin Opportunity
AbbVie (NYSE:ABBV) reported positive topline Phase 1 results for ABBV-295, a long-acting amylin analog for obesity treatment. The trial showed meaningful, dose-dependent reductions in body weight, signaling potential clinical relevance in obesity care. ABBV-295 uses a non-incretin mechanism of action, setting it apart from widely discussed GLP-1 and GIP agonists. The readout marks AbbVie’s entry into the competitive anti-obesity drug market and supports its aim to diversify beyond...